Global Point-of-care Testing (POCT) for Substance Abuse Supply, Demand and Key Producers, 2023-2029
The global Point-of-care Testing (POCT) for Substance Abuse market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Point-of-care Testing (POCT) for Substance Abuse production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Point-of-care Testing (POCT) for Substance Abuse, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Point-of-care Testing (POCT) for Substance Abuse that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Point-of-care Testing (POCT) for Substance Abuse total production and demand, 2018-2029, (K Units)
Global Point-of-care Testing (POCT) for Substance Abuse total production value, 2018-2029, (USD Million)
Global Point-of-care Testing (POCT) for Substance Abuse production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Point-of-care Testing (POCT) for Substance Abuse consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Point-of-care Testing (POCT) for Substance Abuse domestic production, consumption, key domestic manufacturers and share
Global Point-of-care Testing (POCT) for Substance Abuse production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Point-of-care Testing (POCT) for Substance Abuse production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Point-of-care Testing (POCT) for Substance Abuse production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Point-of-care Testing (POCT) for Substance Abuse market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Danaher, Abbott, Siemens, Beijing Hotgen Biotech, Hangzhou Biotest Biotech CO.,LTD, Assure Tech, Orient Gene and Thermo Fisher, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Point-of-care Testing (POCT) for Substance Abuse market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Point-of-care Testing (POCT) for Substance Abuse Market, By Region:
1. How big is the global Point-of-care Testing (POCT) for Substance Abuse market?
2. What is the demand of the global Point-of-care Testing (POCT) for Substance Abuse market?
3. What is the year over year growth of the global Point-of-care Testing (POCT) for Substance Abuse market?
4. What is the production and production value of the global Point-of-care Testing (POCT) for Substance Abuse market?
5. Who are the key producers in the global Point-of-care Testing (POCT) for Substance Abuse market?
6. What are the growth factors driving the market demand?
This report studies the global Point-of-care Testing (POCT) for Substance Abuse production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Point-of-care Testing (POCT) for Substance Abuse, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Point-of-care Testing (POCT) for Substance Abuse that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Point-of-care Testing (POCT) for Substance Abuse total production and demand, 2018-2029, (K Units)
Global Point-of-care Testing (POCT) for Substance Abuse total production value, 2018-2029, (USD Million)
Global Point-of-care Testing (POCT) for Substance Abuse production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Point-of-care Testing (POCT) for Substance Abuse consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Point-of-care Testing (POCT) for Substance Abuse domestic production, consumption, key domestic manufacturers and share
Global Point-of-care Testing (POCT) for Substance Abuse production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Point-of-care Testing (POCT) for Substance Abuse production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Point-of-care Testing (POCT) for Substance Abuse production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Point-of-care Testing (POCT) for Substance Abuse market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Danaher, Abbott, Siemens, Beijing Hotgen Biotech, Hangzhou Biotest Biotech CO.,LTD, Assure Tech, Orient Gene and Thermo Fisher, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Point-of-care Testing (POCT) for Substance Abuse market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Point-of-care Testing (POCT) for Substance Abuse Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Based on Colloidal Gold
- Based on Fluorescence Immunochromatography
- Hospital
- Diagnostic Center
- Road Traffic Safety
- Military
- Others
- Roche
- Danaher
- Abbott
- Siemens
- Beijing Hotgen Biotech
- Hangzhou Biotest Biotech CO.,LTD
- Assure Tech
- Orient Gene
- Thermo Fisher
- Guangzhou Wondfo Biotech Co.,Ltd.
- Hangzhou Alltest Biotech Co.,Ltd.
- Beckman Coulter
- Bio-Rad
- BioMerieux
1. How big is the global Point-of-care Testing (POCT) for Substance Abuse market?
2. What is the demand of the global Point-of-care Testing (POCT) for Substance Abuse market?
3. What is the year over year growth of the global Point-of-care Testing (POCT) for Substance Abuse market?
4. What is the production and production value of the global Point-of-care Testing (POCT) for Substance Abuse market?
5. Who are the key producers in the global Point-of-care Testing (POCT) for Substance Abuse market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Point-of-care Testing (POCT) for Substance Abuse Introduction
1.2 World Point-of-care Testing (POCT) for Substance Abuse Supply & Forecast
1.2.1 World Point-of-care Testing (POCT) for Substance Abuse Production Value (2018 & 2022 & 2029)
1.2.2 World Point-of-care Testing (POCT) for Substance Abuse Production (2018-2029)
1.2.3 World Point-of-care Testing (POCT) for Substance Abuse Pricing Trends (2018-2029)
1.3 World Point-of-care Testing (POCT) for Substance Abuse Production by Region (Based on Production Site)
1.3.1 World Point-of-care Testing (POCT) for Substance Abuse Production Value by Region (2018-2029)
1.3.2 World Point-of-care Testing (POCT) for Substance Abuse Production by Region (2018-2029)
1.3.3 World Point-of-care Testing (POCT) for Substance Abuse Average Price by Region (2018-2029)
1.3.4 North America Point-of-care Testing (POCT) for Substance Abuse Production (2018-2029)
1.3.5 Europe Point-of-care Testing (POCT) for Substance Abuse Production (2018-2029)
1.3.6 China Point-of-care Testing (POCT) for Substance Abuse Production (2018-2029)
1.3.7 Japan Point-of-care Testing (POCT) for Substance Abuse Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Point-of-care Testing (POCT) for Substance Abuse Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Point-of-care Testing (POCT) for Substance Abuse Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Point-of-care Testing (POCT) for Substance Abuse Demand (2018-2029)
2.2 World Point-of-care Testing (POCT) for Substance Abuse Consumption by Region
2.2.1 World Point-of-care Testing (POCT) for Substance Abuse Consumption by Region (2018-2023)
2.2.2 World Point-of-care Testing (POCT) for Substance Abuse Consumption Forecast by Region (2024-2029)
2.3 United States Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029)
2.4 China Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029)
2.5 Europe Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029)
2.6 Japan Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029)
2.7 South Korea Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029)
2.8 ASEAN Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029)
2.9 India Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029)
3 WORLD POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Point-of-care Testing (POCT) for Substance Abuse Production Value by Manufacturer (2018-2023)
3.2 World Point-of-care Testing (POCT) for Substance Abuse Production by Manufacturer (2018-2023)
3.3 World Point-of-care Testing (POCT) for Substance Abuse Average Price by Manufacturer (2018-2023)
3.4 Point-of-care Testing (POCT) for Substance Abuse Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Point-of-care Testing (POCT) for Substance Abuse Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Point-of-care Testing (POCT) for Substance Abuse in 2022
3.5.3 Global Concentration Ratios (CR8) for Point-of-care Testing (POCT) for Substance Abuse in 2022
3.6 Point-of-care Testing (POCT) for Substance Abuse Market: Overall Company Footprint Analysis
3.6.1 Point-of-care Testing (POCT) for Substance Abuse Market: Region Footprint
3.6.2 Point-of-care Testing (POCT) for Substance Abuse Market: Company Product Type Footprint
3.6.3 Point-of-care Testing (POCT) for Substance Abuse Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Point-of-care Testing (POCT) for Substance Abuse Production Value Comparison
4.1.1 United States VS China: Point-of-care Testing (POCT) for Substance Abuse Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Point-of-care Testing (POCT) for Substance Abuse Production Comparison
4.2.1 United States VS China: Point-of-care Testing (POCT) for Substance Abuse Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Point-of-care Testing (POCT) for Substance Abuse Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Point-of-care Testing (POCT) for Substance Abuse Consumption Comparison
4.3.1 United States VS China: Point-of-care Testing (POCT) for Substance Abuse Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Point-of-care Testing (POCT) for Substance Abuse Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Point-of-care Testing (POCT) for Substance Abuse Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Point-of-care Testing (POCT) for Substance Abuse Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Value (2018-2023)
4.4.3 United States Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production (2018-2023)
4.5 China Based Point-of-care Testing (POCT) for Substance Abuse Manufacturers and Market Share
4.5.1 China Based Point-of-care Testing (POCT) for Substance Abuse Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Value (2018-2023)
4.5.3 China Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production (2018-2023)
4.6 Rest of World Based Point-of-care Testing (POCT) for Substance Abuse Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Point-of-care Testing (POCT) for Substance Abuse Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Point-of-care Testing (POCT) for Substance Abuse Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Based on Colloidal Gold
5.2.2 Based on Fluorescence Immunochromatography
5.3 Market Segment by Type
5.3.1 World Point-of-care Testing (POCT) for Substance Abuse Production by Type (2018-2029)
5.3.2 World Point-of-care Testing (POCT) for Substance Abuse Production Value by Type (2018-2029)
5.3.3 World Point-of-care Testing (POCT) for Substance Abuse Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Point-of-care Testing (POCT) for Substance Abuse Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Diagnostic Center
6.2.3 Road Traffic Safety
6.2.4 Military
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Point-of-care Testing (POCT) for Substance Abuse Production by Application (2018-2029)
6.3.2 World Point-of-care Testing (POCT) for Substance Abuse Production Value by Application (2018-2029)
6.3.3 World Point-of-care Testing (POCT) for Substance Abuse Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.1.4 Roche Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Danaher
7.2.1 Danaher Details
7.2.2 Danaher Major Business
7.2.3 Danaher Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.2.4 Danaher Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Danaher Recent Developments/Updates
7.2.6 Danaher Competitive Strengths & Weaknesses
7.3 Abbott
7.3.1 Abbott Details
7.3.2 Abbott Major Business
7.3.3 Abbott Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.3.4 Abbott Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Abbott Recent Developments/Updates
7.3.6 Abbott Competitive Strengths & Weaknesses
7.4 Siemens
7.4.1 Siemens Details
7.4.2 Siemens Major Business
7.4.3 Siemens Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.4.4 Siemens Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Siemens Recent Developments/Updates
7.4.6 Siemens Competitive Strengths & Weaknesses
7.5 Beijing Hotgen Biotech
7.5.1 Beijing Hotgen Biotech Details
7.5.2 Beijing Hotgen Biotech Major Business
7.5.3 Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.5.4 Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Beijing Hotgen Biotech Recent Developments/Updates
7.5.6 Beijing Hotgen Biotech Competitive Strengths & Weaknesses
7.6 Hangzhou Biotest Biotech CO.,LTD
7.6.1 Hangzhou Biotest Biotech CO.,LTD Details
7.6.2 Hangzhou Biotest Biotech CO.,LTD Major Business
7.6.3 Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.6.4 Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Hangzhou Biotest Biotech CO.,LTD Recent Developments/Updates
7.6.6 Hangzhou Biotest Biotech CO.,LTD Competitive Strengths & Weaknesses
7.7 Assure Tech
7.7.1 Assure Tech Details
7.7.2 Assure Tech Major Business
7.7.3 Assure Tech Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.7.4 Assure Tech Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Assure Tech Recent Developments/Updates
7.7.6 Assure Tech Competitive Strengths & Weaknesses
7.8 Orient Gene
7.8.1 Orient Gene Details
7.8.2 Orient Gene Major Business
7.8.3 Orient Gene Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.8.4 Orient Gene Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Orient Gene Recent Developments/Updates
7.8.6 Orient Gene Competitive Strengths & Weaknesses
7.9 Thermo Fisher
7.9.1 Thermo Fisher Details
7.9.2 Thermo Fisher Major Business
7.9.3 Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.9.4 Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Thermo Fisher Recent Developments/Updates
7.9.6 Thermo Fisher Competitive Strengths & Weaknesses
7.10 Guangzhou Wondfo Biotech Co.,Ltd.
7.10.1 Guangzhou Wondfo Biotech Co.,Ltd. Details
7.10.2 Guangzhou Wondfo Biotech Co.,Ltd. Major Business
7.10.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.10.4 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
7.10.6 Guangzhou Wondfo Biotech Co.,Ltd. Competitive Strengths & Weaknesses
7.11 Hangzhou Alltest Biotech Co.,Ltd.
7.11.1 Hangzhou Alltest Biotech Co.,Ltd. Details
7.11.2 Hangzhou Alltest Biotech Co.,Ltd. Major Business
7.11.3 Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.11.4 Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Hangzhou Alltest Biotech Co.,Ltd. Recent Developments/Updates
7.11.6 Hangzhou Alltest Biotech Co.,Ltd. Competitive Strengths & Weaknesses
7.12 Beckman Coulter
7.12.1 Beckman Coulter Details
7.12.2 Beckman Coulter Major Business
7.12.3 Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.12.4 Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Beckman Coulter Recent Developments/Updates
7.12.6 Beckman Coulter Competitive Strengths & Weaknesses
7.13 Bio-Rad
7.13.1 Bio-Rad Details
7.13.2 Bio-Rad Major Business
7.13.3 Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.13.4 Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Bio-Rad Recent Developments/Updates
7.13.6 Bio-Rad Competitive Strengths & Weaknesses
7.14 BioMerieux
7.14.1 BioMerieux Details
7.14.2 BioMerieux Major Business
7.14.3 BioMerieux Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.14.4 BioMerieux Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 BioMerieux Recent Developments/Updates
7.14.6 BioMerieux Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Point-of-care Testing (POCT) for Substance Abuse Industry Chain
8.2 Point-of-care Testing (POCT) for Substance Abuse Upstream Analysis
8.2.1 Point-of-care Testing (POCT) for Substance Abuse Core Raw Materials
8.2.2 Main Manufacturers of Point-of-care Testing (POCT) for Substance Abuse Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Point-of-care Testing (POCT) for Substance Abuse Production Mode
8.6 Point-of-care Testing (POCT) for Substance Abuse Procurement Model
8.7 Point-of-care Testing (POCT) for Substance Abuse Industry Sales Model and Sales Channels
8.7.1 Point-of-care Testing (POCT) for Substance Abuse Sales Model
8.7.2 Point-of-care Testing (POCT) for Substance Abuse Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Point-of-care Testing (POCT) for Substance Abuse Introduction
1.2 World Point-of-care Testing (POCT) for Substance Abuse Supply & Forecast
1.2.1 World Point-of-care Testing (POCT) for Substance Abuse Production Value (2018 & 2022 & 2029)
1.2.2 World Point-of-care Testing (POCT) for Substance Abuse Production (2018-2029)
1.2.3 World Point-of-care Testing (POCT) for Substance Abuse Pricing Trends (2018-2029)
1.3 World Point-of-care Testing (POCT) for Substance Abuse Production by Region (Based on Production Site)
1.3.1 World Point-of-care Testing (POCT) for Substance Abuse Production Value by Region (2018-2029)
1.3.2 World Point-of-care Testing (POCT) for Substance Abuse Production by Region (2018-2029)
1.3.3 World Point-of-care Testing (POCT) for Substance Abuse Average Price by Region (2018-2029)
1.3.4 North America Point-of-care Testing (POCT) for Substance Abuse Production (2018-2029)
1.3.5 Europe Point-of-care Testing (POCT) for Substance Abuse Production (2018-2029)
1.3.6 China Point-of-care Testing (POCT) for Substance Abuse Production (2018-2029)
1.3.7 Japan Point-of-care Testing (POCT) for Substance Abuse Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Point-of-care Testing (POCT) for Substance Abuse Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Point-of-care Testing (POCT) for Substance Abuse Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Point-of-care Testing (POCT) for Substance Abuse Demand (2018-2029)
2.2 World Point-of-care Testing (POCT) for Substance Abuse Consumption by Region
2.2.1 World Point-of-care Testing (POCT) for Substance Abuse Consumption by Region (2018-2023)
2.2.2 World Point-of-care Testing (POCT) for Substance Abuse Consumption Forecast by Region (2024-2029)
2.3 United States Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029)
2.4 China Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029)
2.5 Europe Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029)
2.6 Japan Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029)
2.7 South Korea Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029)
2.8 ASEAN Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029)
2.9 India Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029)
3 WORLD POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Point-of-care Testing (POCT) for Substance Abuse Production Value by Manufacturer (2018-2023)
3.2 World Point-of-care Testing (POCT) for Substance Abuse Production by Manufacturer (2018-2023)
3.3 World Point-of-care Testing (POCT) for Substance Abuse Average Price by Manufacturer (2018-2023)
3.4 Point-of-care Testing (POCT) for Substance Abuse Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Point-of-care Testing (POCT) for Substance Abuse Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Point-of-care Testing (POCT) for Substance Abuse in 2022
3.5.3 Global Concentration Ratios (CR8) for Point-of-care Testing (POCT) for Substance Abuse in 2022
3.6 Point-of-care Testing (POCT) for Substance Abuse Market: Overall Company Footprint Analysis
3.6.1 Point-of-care Testing (POCT) for Substance Abuse Market: Region Footprint
3.6.2 Point-of-care Testing (POCT) for Substance Abuse Market: Company Product Type Footprint
3.6.3 Point-of-care Testing (POCT) for Substance Abuse Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Point-of-care Testing (POCT) for Substance Abuse Production Value Comparison
4.1.1 United States VS China: Point-of-care Testing (POCT) for Substance Abuse Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Point-of-care Testing (POCT) for Substance Abuse Production Comparison
4.2.1 United States VS China: Point-of-care Testing (POCT) for Substance Abuse Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Point-of-care Testing (POCT) for Substance Abuse Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Point-of-care Testing (POCT) for Substance Abuse Consumption Comparison
4.3.1 United States VS China: Point-of-care Testing (POCT) for Substance Abuse Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Point-of-care Testing (POCT) for Substance Abuse Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Point-of-care Testing (POCT) for Substance Abuse Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Point-of-care Testing (POCT) for Substance Abuse Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Value (2018-2023)
4.4.3 United States Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production (2018-2023)
4.5 China Based Point-of-care Testing (POCT) for Substance Abuse Manufacturers and Market Share
4.5.1 China Based Point-of-care Testing (POCT) for Substance Abuse Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Value (2018-2023)
4.5.3 China Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production (2018-2023)
4.6 Rest of World Based Point-of-care Testing (POCT) for Substance Abuse Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Point-of-care Testing (POCT) for Substance Abuse Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Point-of-care Testing (POCT) for Substance Abuse Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Based on Colloidal Gold
5.2.2 Based on Fluorescence Immunochromatography
5.3 Market Segment by Type
5.3.1 World Point-of-care Testing (POCT) for Substance Abuse Production by Type (2018-2029)
5.3.2 World Point-of-care Testing (POCT) for Substance Abuse Production Value by Type (2018-2029)
5.3.3 World Point-of-care Testing (POCT) for Substance Abuse Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Point-of-care Testing (POCT) for Substance Abuse Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Diagnostic Center
6.2.3 Road Traffic Safety
6.2.4 Military
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Point-of-care Testing (POCT) for Substance Abuse Production by Application (2018-2029)
6.3.2 World Point-of-care Testing (POCT) for Substance Abuse Production Value by Application (2018-2029)
6.3.3 World Point-of-care Testing (POCT) for Substance Abuse Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.1.4 Roche Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Danaher
7.2.1 Danaher Details
7.2.2 Danaher Major Business
7.2.3 Danaher Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.2.4 Danaher Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Danaher Recent Developments/Updates
7.2.6 Danaher Competitive Strengths & Weaknesses
7.3 Abbott
7.3.1 Abbott Details
7.3.2 Abbott Major Business
7.3.3 Abbott Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.3.4 Abbott Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Abbott Recent Developments/Updates
7.3.6 Abbott Competitive Strengths & Weaknesses
7.4 Siemens
7.4.1 Siemens Details
7.4.2 Siemens Major Business
7.4.3 Siemens Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.4.4 Siemens Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Siemens Recent Developments/Updates
7.4.6 Siemens Competitive Strengths & Weaknesses
7.5 Beijing Hotgen Biotech
7.5.1 Beijing Hotgen Biotech Details
7.5.2 Beijing Hotgen Biotech Major Business
7.5.3 Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.5.4 Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Beijing Hotgen Biotech Recent Developments/Updates
7.5.6 Beijing Hotgen Biotech Competitive Strengths & Weaknesses
7.6 Hangzhou Biotest Biotech CO.,LTD
7.6.1 Hangzhou Biotest Biotech CO.,LTD Details
7.6.2 Hangzhou Biotest Biotech CO.,LTD Major Business
7.6.3 Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.6.4 Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Hangzhou Biotest Biotech CO.,LTD Recent Developments/Updates
7.6.6 Hangzhou Biotest Biotech CO.,LTD Competitive Strengths & Weaknesses
7.7 Assure Tech
7.7.1 Assure Tech Details
7.7.2 Assure Tech Major Business
7.7.3 Assure Tech Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.7.4 Assure Tech Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Assure Tech Recent Developments/Updates
7.7.6 Assure Tech Competitive Strengths & Weaknesses
7.8 Orient Gene
7.8.1 Orient Gene Details
7.8.2 Orient Gene Major Business
7.8.3 Orient Gene Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.8.4 Orient Gene Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Orient Gene Recent Developments/Updates
7.8.6 Orient Gene Competitive Strengths & Weaknesses
7.9 Thermo Fisher
7.9.1 Thermo Fisher Details
7.9.2 Thermo Fisher Major Business
7.9.3 Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.9.4 Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Thermo Fisher Recent Developments/Updates
7.9.6 Thermo Fisher Competitive Strengths & Weaknesses
7.10 Guangzhou Wondfo Biotech Co.,Ltd.
7.10.1 Guangzhou Wondfo Biotech Co.,Ltd. Details
7.10.2 Guangzhou Wondfo Biotech Co.,Ltd. Major Business
7.10.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.10.4 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
7.10.6 Guangzhou Wondfo Biotech Co.,Ltd. Competitive Strengths & Weaknesses
7.11 Hangzhou Alltest Biotech Co.,Ltd.
7.11.1 Hangzhou Alltest Biotech Co.,Ltd. Details
7.11.2 Hangzhou Alltest Biotech Co.,Ltd. Major Business
7.11.3 Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.11.4 Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Hangzhou Alltest Biotech Co.,Ltd. Recent Developments/Updates
7.11.6 Hangzhou Alltest Biotech Co.,Ltd. Competitive Strengths & Weaknesses
7.12 Beckman Coulter
7.12.1 Beckman Coulter Details
7.12.2 Beckman Coulter Major Business
7.12.3 Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.12.4 Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Beckman Coulter Recent Developments/Updates
7.12.6 Beckman Coulter Competitive Strengths & Weaknesses
7.13 Bio-Rad
7.13.1 Bio-Rad Details
7.13.2 Bio-Rad Major Business
7.13.3 Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.13.4 Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Bio-Rad Recent Developments/Updates
7.13.6 Bio-Rad Competitive Strengths & Weaknesses
7.14 BioMerieux
7.14.1 BioMerieux Details
7.14.2 BioMerieux Major Business
7.14.3 BioMerieux Point-of-care Testing (POCT) for Substance Abuse Product and Services
7.14.4 BioMerieux Point-of-care Testing (POCT) for Substance Abuse Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 BioMerieux Recent Developments/Updates
7.14.6 BioMerieux Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Point-of-care Testing (POCT) for Substance Abuse Industry Chain
8.2 Point-of-care Testing (POCT) for Substance Abuse Upstream Analysis
8.2.1 Point-of-care Testing (POCT) for Substance Abuse Core Raw Materials
8.2.2 Main Manufacturers of Point-of-care Testing (POCT) for Substance Abuse Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Point-of-care Testing (POCT) for Substance Abuse Production Mode
8.6 Point-of-care Testing (POCT) for Substance Abuse Procurement Model
8.7 Point-of-care Testing (POCT) for Substance Abuse Industry Sales Model and Sales Channels
8.7.1 Point-of-care Testing (POCT) for Substance Abuse Sales Model
8.7.2 Point-of-care Testing (POCT) for Substance Abuse Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Region (2018-2023) & (USD Million)
Table 3. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Region (2024-2029) & (USD Million)
Table 4. World Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share by Region (2018-2023)
Table 5. World Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share by Region (2024-2029)
Table 6. World Point-of-care Testing (POCT) for Substance Abuse Production by Region (2018-2023) & (K Units)
Table 7. World Point-of-care Testing (POCT) for Substance Abuse Production by Region (2024-2029) & (K Units)
Table 8. World Point-of-care Testing (POCT) for Substance Abuse Production Market Share by Region (2018-2023)
Table 9. World Point-of-care Testing (POCT) for Substance Abuse Production Market Share by Region (2024-2029)
Table 10. World Point-of-care Testing (POCT) for Substance Abuse Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Point-of-care Testing (POCT) for Substance Abuse Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Point-of-care Testing (POCT) for Substance Abuse Major Market Trends
Table 13. World Point-of-care Testing (POCT) for Substance Abuse Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Point-of-care Testing (POCT) for Substance Abuse Consumption by Region (2018-2023) & (K Units)
Table 15. World Point-of-care Testing (POCT) for Substance Abuse Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Point-of-care Testing (POCT) for Substance Abuse Producers in 2022
Table 18. World Point-of-care Testing (POCT) for Substance Abuse Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Point-of-care Testing (POCT) for Substance Abuse Producers in 2022
Table 20. World Point-of-care Testing (POCT) for Substance Abuse Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Point-of-care Testing (POCT) for Substance Abuse Company Evaluation Quadrant
Table 22. World Point-of-care Testing (POCT) for Substance Abuse Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Point-of-care Testing (POCT) for Substance Abuse Production Site of Key Manufacturer
Table 24. Point-of-care Testing (POCT) for Substance Abuse Market: Company Product Type Footprint
Table 25. Point-of-care Testing (POCT) for Substance Abuse Market: Company Product Application Footprint
Table 26. Point-of-care Testing (POCT) for Substance Abuse Competitive Factors
Table 27. Point-of-care Testing (POCT) for Substance Abuse New Entrant and Capacity Expansion Plans
Table 28. Point-of-care Testing (POCT) for Substance Abuse Mergers & Acquisitions Activity
Table 29. United States VS China Point-of-care Testing (POCT) for Substance Abuse Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Point-of-care Testing (POCT) for Substance Abuse Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Point-of-care Testing (POCT) for Substance Abuse Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Point-of-care Testing (POCT) for Substance Abuse Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Market Share (2018-2023)
Table 37. China Based Point-of-care Testing (POCT) for Substance Abuse Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Market Share (2018-2023)
Table 42. Rest of World Based Point-of-care Testing (POCT) for Substance Abuse Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Market Share (2018-2023)
Table 47. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Point-of-care Testing (POCT) for Substance Abuse Production by Type (2018-2023) & (K Units)
Table 49. World Point-of-care Testing (POCT) for Substance Abuse Production by Type (2024-2029) & (K Units)
Table 50. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Type (2018-2023) & (USD Million)
Table 51. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Type (2024-2029) & (USD Million)
Table 52. World Point-of-care Testing (POCT) for Substance Abuse Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Point-of-care Testing (POCT) for Substance Abuse Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Point-of-care Testing (POCT) for Substance Abuse Production by Application (2018-2023) & (K Units)
Table 56. World Point-of-care Testing (POCT) for Substance Abuse Production by Application (2024-2029) & (K Units)
Table 57. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Application (2018-2023) & (USD Million)
Table 58. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Application (2024-2029) & (USD Million)
Table 59. World Point-of-care Testing (POCT) for Substance Abuse Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Point-of-care Testing (POCT) for Substance Abuse Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Roche Basic Information, Manufacturing Base and Competitors
Table 62. Roche Major Business
Table 63. Roche Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 64. Roche Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Roche Recent Developments/Updates
Table 66. Roche Competitive Strengths & Weaknesses
Table 67. Danaher Basic Information, Manufacturing Base and Competitors
Table 68. Danaher Major Business
Table 69. Danaher Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 70. Danaher Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Danaher Recent Developments/Updates
Table 72. Danaher Competitive Strengths & Weaknesses
Table 73. Abbott Basic Information, Manufacturing Base and Competitors
Table 74. Abbott Major Business
Table 75. Abbott Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 76. Abbott Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Abbott Recent Developments/Updates
Table 78. Abbott Competitive Strengths & Weaknesses
Table 79. Siemens Basic Information, Manufacturing Base and Competitors
Table 80. Siemens Major Business
Table 81. Siemens Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 82. Siemens Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Siemens Recent Developments/Updates
Table 84. Siemens Competitive Strengths & Weaknesses
Table 85. Beijing Hotgen Biotech Basic Information, Manufacturing Base and Competitors
Table 86. Beijing Hotgen Biotech Major Business
Table 87. Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 88. Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Beijing Hotgen Biotech Recent Developments/Updates
Table 90. Beijing Hotgen Biotech Competitive Strengths & Weaknesses
Table 91. Hangzhou Biotest Biotech CO.,LTD Basic Information, Manufacturing Base and Competitors
Table 92. Hangzhou Biotest Biotech CO.,LTD Major Business
Table 93. Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 94. Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Hangzhou Biotest Biotech CO.,LTD Recent Developments/Updates
Table 96. Hangzhou Biotest Biotech CO.,LTD Competitive Strengths & Weaknesses
Table 97. Assure Tech Basic Information, Manufacturing Base and Competitors
Table 98. Assure Tech Major Business
Table 99. Assure Tech Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 100. Assure Tech Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Assure Tech Recent Developments/Updates
Table 102. Assure Tech Competitive Strengths & Weaknesses
Table 103. Orient Gene Basic Information, Manufacturing Base and Competitors
Table 104. Orient Gene Major Business
Table 105. Orient Gene Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 106. Orient Gene Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Orient Gene Recent Developments/Updates
Table 108. Orient Gene Competitive Strengths & Weaknesses
Table 109. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 110. Thermo Fisher Major Business
Table 111. Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 112. Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Thermo Fisher Recent Developments/Updates
Table 114. Thermo Fisher Competitive Strengths & Weaknesses
Table 115. Guangzhou Wondfo Biotech Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 116. Guangzhou Wondfo Biotech Co.,Ltd. Major Business
Table 117. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 118. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
Table 120. Guangzhou Wondfo Biotech Co.,Ltd. Competitive Strengths & Weaknesses
Table 121. Hangzhou Alltest Biotech Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 122. Hangzhou Alltest Biotech Co.,Ltd. Major Business
Table 123. Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 124. Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Hangzhou Alltest Biotech Co.,Ltd. Recent Developments/Updates
Table 126. Hangzhou Alltest Biotech Co.,Ltd. Competitive Strengths & Weaknesses
Table 127. Beckman Coulter Basic Information, Manufacturing Base and Competitors
Table 128. Beckman Coulter Major Business
Table 129. Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 130. Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Beckman Coulter Recent Developments/Updates
Table 132. Beckman Coulter Competitive Strengths & Weaknesses
Table 133. Bio-Rad Basic Information, Manufacturing Base and Competitors
Table 134. Bio-Rad Major Business
Table 135. Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 136. Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Bio-Rad Recent Developments/Updates
Table 138. BioMerieux Basic Information, Manufacturing Base and Competitors
Table 139. BioMerieux Major Business
Table 140. BioMerieux Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 141. BioMerieux Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Global Key Players of Point-of-care Testing (POCT) for Substance Abuse Upstream (Raw Materials)
Table 143. Point-of-care Testing (POCT) for Substance Abuse Typical Customers
Table 144. Point-of-care Testing (POCT) for Substance Abuse Typical Distributors
Table 1. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Region (2018-2023) & (USD Million)
Table 3. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Region (2024-2029) & (USD Million)
Table 4. World Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share by Region (2018-2023)
Table 5. World Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share by Region (2024-2029)
Table 6. World Point-of-care Testing (POCT) for Substance Abuse Production by Region (2018-2023) & (K Units)
Table 7. World Point-of-care Testing (POCT) for Substance Abuse Production by Region (2024-2029) & (K Units)
Table 8. World Point-of-care Testing (POCT) for Substance Abuse Production Market Share by Region (2018-2023)
Table 9. World Point-of-care Testing (POCT) for Substance Abuse Production Market Share by Region (2024-2029)
Table 10. World Point-of-care Testing (POCT) for Substance Abuse Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Point-of-care Testing (POCT) for Substance Abuse Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Point-of-care Testing (POCT) for Substance Abuse Major Market Trends
Table 13. World Point-of-care Testing (POCT) for Substance Abuse Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Point-of-care Testing (POCT) for Substance Abuse Consumption by Region (2018-2023) & (K Units)
Table 15. World Point-of-care Testing (POCT) for Substance Abuse Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Point-of-care Testing (POCT) for Substance Abuse Producers in 2022
Table 18. World Point-of-care Testing (POCT) for Substance Abuse Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Point-of-care Testing (POCT) for Substance Abuse Producers in 2022
Table 20. World Point-of-care Testing (POCT) for Substance Abuse Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Point-of-care Testing (POCT) for Substance Abuse Company Evaluation Quadrant
Table 22. World Point-of-care Testing (POCT) for Substance Abuse Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Point-of-care Testing (POCT) for Substance Abuse Production Site of Key Manufacturer
Table 24. Point-of-care Testing (POCT) for Substance Abuse Market: Company Product Type Footprint
Table 25. Point-of-care Testing (POCT) for Substance Abuse Market: Company Product Application Footprint
Table 26. Point-of-care Testing (POCT) for Substance Abuse Competitive Factors
Table 27. Point-of-care Testing (POCT) for Substance Abuse New Entrant and Capacity Expansion Plans
Table 28. Point-of-care Testing (POCT) for Substance Abuse Mergers & Acquisitions Activity
Table 29. United States VS China Point-of-care Testing (POCT) for Substance Abuse Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Point-of-care Testing (POCT) for Substance Abuse Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Point-of-care Testing (POCT) for Substance Abuse Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Point-of-care Testing (POCT) for Substance Abuse Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Market Share (2018-2023)
Table 37. China Based Point-of-care Testing (POCT) for Substance Abuse Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Market Share (2018-2023)
Table 42. Rest of World Based Point-of-care Testing (POCT) for Substance Abuse Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Market Share (2018-2023)
Table 47. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Point-of-care Testing (POCT) for Substance Abuse Production by Type (2018-2023) & (K Units)
Table 49. World Point-of-care Testing (POCT) for Substance Abuse Production by Type (2024-2029) & (K Units)
Table 50. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Type (2018-2023) & (USD Million)
Table 51. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Type (2024-2029) & (USD Million)
Table 52. World Point-of-care Testing (POCT) for Substance Abuse Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Point-of-care Testing (POCT) for Substance Abuse Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Point-of-care Testing (POCT) for Substance Abuse Production by Application (2018-2023) & (K Units)
Table 56. World Point-of-care Testing (POCT) for Substance Abuse Production by Application (2024-2029) & (K Units)
Table 57. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Application (2018-2023) & (USD Million)
Table 58. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Application (2024-2029) & (USD Million)
Table 59. World Point-of-care Testing (POCT) for Substance Abuse Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Point-of-care Testing (POCT) for Substance Abuse Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Roche Basic Information, Manufacturing Base and Competitors
Table 62. Roche Major Business
Table 63. Roche Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 64. Roche Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Roche Recent Developments/Updates
Table 66. Roche Competitive Strengths & Weaknesses
Table 67. Danaher Basic Information, Manufacturing Base and Competitors
Table 68. Danaher Major Business
Table 69. Danaher Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 70. Danaher Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Danaher Recent Developments/Updates
Table 72. Danaher Competitive Strengths & Weaknesses
Table 73. Abbott Basic Information, Manufacturing Base and Competitors
Table 74. Abbott Major Business
Table 75. Abbott Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 76. Abbott Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Abbott Recent Developments/Updates
Table 78. Abbott Competitive Strengths & Weaknesses
Table 79. Siemens Basic Information, Manufacturing Base and Competitors
Table 80. Siemens Major Business
Table 81. Siemens Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 82. Siemens Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Siemens Recent Developments/Updates
Table 84. Siemens Competitive Strengths & Weaknesses
Table 85. Beijing Hotgen Biotech Basic Information, Manufacturing Base and Competitors
Table 86. Beijing Hotgen Biotech Major Business
Table 87. Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 88. Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Beijing Hotgen Biotech Recent Developments/Updates
Table 90. Beijing Hotgen Biotech Competitive Strengths & Weaknesses
Table 91. Hangzhou Biotest Biotech CO.,LTD Basic Information, Manufacturing Base and Competitors
Table 92. Hangzhou Biotest Biotech CO.,LTD Major Business
Table 93. Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 94. Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Hangzhou Biotest Biotech CO.,LTD Recent Developments/Updates
Table 96. Hangzhou Biotest Biotech CO.,LTD Competitive Strengths & Weaknesses
Table 97. Assure Tech Basic Information, Manufacturing Base and Competitors
Table 98. Assure Tech Major Business
Table 99. Assure Tech Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 100. Assure Tech Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Assure Tech Recent Developments/Updates
Table 102. Assure Tech Competitive Strengths & Weaknesses
Table 103. Orient Gene Basic Information, Manufacturing Base and Competitors
Table 104. Orient Gene Major Business
Table 105. Orient Gene Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 106. Orient Gene Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Orient Gene Recent Developments/Updates
Table 108. Orient Gene Competitive Strengths & Weaknesses
Table 109. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 110. Thermo Fisher Major Business
Table 111. Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 112. Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Thermo Fisher Recent Developments/Updates
Table 114. Thermo Fisher Competitive Strengths & Weaknesses
Table 115. Guangzhou Wondfo Biotech Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 116. Guangzhou Wondfo Biotech Co.,Ltd. Major Business
Table 117. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 118. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
Table 120. Guangzhou Wondfo Biotech Co.,Ltd. Competitive Strengths & Weaknesses
Table 121. Hangzhou Alltest Biotech Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 122. Hangzhou Alltest Biotech Co.,Ltd. Major Business
Table 123. Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 124. Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Hangzhou Alltest Biotech Co.,Ltd. Recent Developments/Updates
Table 126. Hangzhou Alltest Biotech Co.,Ltd. Competitive Strengths & Weaknesses
Table 127. Beckman Coulter Basic Information, Manufacturing Base and Competitors
Table 128. Beckman Coulter Major Business
Table 129. Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 130. Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Beckman Coulter Recent Developments/Updates
Table 132. Beckman Coulter Competitive Strengths & Weaknesses
Table 133. Bio-Rad Basic Information, Manufacturing Base and Competitors
Table 134. Bio-Rad Major Business
Table 135. Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 136. Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Bio-Rad Recent Developments/Updates
Table 138. BioMerieux Basic Information, Manufacturing Base and Competitors
Table 139. BioMerieux Major Business
Table 140. BioMerieux Point-of-care Testing (POCT) for Substance Abuse Product and Services
Table 141. BioMerieux Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Global Key Players of Point-of-care Testing (POCT) for Substance Abuse Upstream (Raw Materials)
Table 143. Point-of-care Testing (POCT) for Substance Abuse Typical Customers
Table 144. Point-of-care Testing (POCT) for Substance Abuse Typical Distributors
LIST OF FIGURES
Figure 1. Point-of-care Testing (POCT) for Substance Abuse Picture
Figure 2. World Point-of-care Testing (POCT) for Substance Abuse Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Point-of-care Testing (POCT) for Substance Abuse Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Point-of-care Testing (POCT) for Substance Abuse Production (2018-2029) & (K Units)
Figure 5. World Point-of-care Testing (POCT) for Substance Abuse Average Price (2018-2029) & (US$/Unit)
Figure 6. World Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share by Region (2018-2029)
Figure 7. World Point-of-care Testing (POCT) for Substance Abuse Production Market Share by Region (2018-2029)
Figure 8. North America Point-of-care Testing (POCT) for Substance Abuse Production (2018-2029) & (K Units)
Figure 9. Europe Point-of-care Testing (POCT) for Substance Abuse Production (2018-2029) & (K Units)
Figure 10. China Point-of-care Testing (POCT) for Substance Abuse Production (2018-2029) & (K Units)
Figure 11. Japan Point-of-care Testing (POCT) for Substance Abuse Production (2018-2029) & (K Units)
Figure 12. Point-of-care Testing (POCT) for Substance Abuse Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029) & (K Units)
Figure 15. World Point-of-care Testing (POCT) for Substance Abuse Consumption Market Share by Region (2018-2029)
Figure 16. United States Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029) & (K Units)
Figure 17. China Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029) & (K Units)
Figure 18. Europe Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029) & (K Units)
Figure 19. Japan Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029) & (K Units)
Figure 20. South Korea Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029) & (K Units)
Figure 22. India Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Point-of-care Testing (POCT) for Substance Abuse by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Point-of-care Testing (POCT) for Substance Abuse Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Point-of-care Testing (POCT) for Substance Abuse Markets in 2022
Figure 26. United States VS China: Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Point-of-care Testing (POCT) for Substance Abuse Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Point-of-care Testing (POCT) for Substance Abuse Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Market Share 2022
Figure 30. China Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Market Share 2022
Figure 32. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share by Type in 2022
Figure 34. Based on Colloidal Gold
Figure 35. Based on Fluorescence Immunochromatography
Figure 36. World Point-of-care Testing (POCT) for Substance Abuse Production Market Share by Type (2018-2029)
Figure 37. World Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share by Type (2018-2029)
Figure 38. World Point-of-care Testing (POCT) for Substance Abuse Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Diagnostic Center
Figure 43. Road Traffic Safety
Figure 44. Military
Figure 45. Others
Figure 46. World Point-of-care Testing (POCT) for Substance Abuse Production Market Share by Application (2018-2029)
Figure 47. World Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share by Application (2018-2029)
Figure 48. World Point-of-care Testing (POCT) for Substance Abuse Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Point-of-care Testing (POCT) for Substance Abuse Industry Chain
Figure 50. Point-of-care Testing (POCT) for Substance Abuse Procurement Model
Figure 51. Point-of-care Testing (POCT) for Substance Abuse Sales Model
Figure 52. Point-of-care Testing (POCT) for Substance Abuse Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Point-of-care Testing (POCT) for Substance Abuse Picture
Figure 2. World Point-of-care Testing (POCT) for Substance Abuse Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Point-of-care Testing (POCT) for Substance Abuse Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Point-of-care Testing (POCT) for Substance Abuse Production (2018-2029) & (K Units)
Figure 5. World Point-of-care Testing (POCT) for Substance Abuse Average Price (2018-2029) & (US$/Unit)
Figure 6. World Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share by Region (2018-2029)
Figure 7. World Point-of-care Testing (POCT) for Substance Abuse Production Market Share by Region (2018-2029)
Figure 8. North America Point-of-care Testing (POCT) for Substance Abuse Production (2018-2029) & (K Units)
Figure 9. Europe Point-of-care Testing (POCT) for Substance Abuse Production (2018-2029) & (K Units)
Figure 10. China Point-of-care Testing (POCT) for Substance Abuse Production (2018-2029) & (K Units)
Figure 11. Japan Point-of-care Testing (POCT) for Substance Abuse Production (2018-2029) & (K Units)
Figure 12. Point-of-care Testing (POCT) for Substance Abuse Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029) & (K Units)
Figure 15. World Point-of-care Testing (POCT) for Substance Abuse Consumption Market Share by Region (2018-2029)
Figure 16. United States Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029) & (K Units)
Figure 17. China Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029) & (K Units)
Figure 18. Europe Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029) & (K Units)
Figure 19. Japan Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029) & (K Units)
Figure 20. South Korea Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029) & (K Units)
Figure 22. India Point-of-care Testing (POCT) for Substance Abuse Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Point-of-care Testing (POCT) for Substance Abuse by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Point-of-care Testing (POCT) for Substance Abuse Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Point-of-care Testing (POCT) for Substance Abuse Markets in 2022
Figure 26. United States VS China: Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Point-of-care Testing (POCT) for Substance Abuse Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Point-of-care Testing (POCT) for Substance Abuse Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Market Share 2022
Figure 30. China Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Substance Abuse Production Market Share 2022
Figure 32. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share by Type in 2022
Figure 34. Based on Colloidal Gold
Figure 35. Based on Fluorescence Immunochromatography
Figure 36. World Point-of-care Testing (POCT) for Substance Abuse Production Market Share by Type (2018-2029)
Figure 37. World Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share by Type (2018-2029)
Figure 38. World Point-of-care Testing (POCT) for Substance Abuse Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Point-of-care Testing (POCT) for Substance Abuse Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Diagnostic Center
Figure 43. Road Traffic Safety
Figure 44. Military
Figure 45. Others
Figure 46. World Point-of-care Testing (POCT) for Substance Abuse Production Market Share by Application (2018-2029)
Figure 47. World Point-of-care Testing (POCT) for Substance Abuse Production Value Market Share by Application (2018-2029)
Figure 48. World Point-of-care Testing (POCT) for Substance Abuse Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Point-of-care Testing (POCT) for Substance Abuse Industry Chain
Figure 50. Point-of-care Testing (POCT) for Substance Abuse Procurement Model
Figure 51. Point-of-care Testing (POCT) for Substance Abuse Sales Model
Figure 52. Point-of-care Testing (POCT) for Substance Abuse Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
